India, June 4 -- image credit- shutterstock

Researchers at the Indian Institute of Science (IISc), Bengaluru have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood clotting caused by conditions like pulmonary thromboembolism (PTE).

These "nanozymes" work by controllingtoxic Reactive Oxygen Species (ROS) levels, thereby preventing the over-activation of platelets that leads to excess clot formation or thrombosis.

The team injected the nanozyme in a mouse model of PTE and found that it significantly reduced thrombosis and increased the animals' survival rates. They also observed the weight, behaviour, and blood parameters of the animal for up to five days after injecting the nanozym...